A US launch lives inside the FDA monograph. A European or UK launch follows cosmetic law. The formula can stay almost identical. The proof behind it, the label on the bottle, and the documents your OEM must hand you change completely. Settle the market before you settle the SPF or the minimum order quantity, and everything else in the brief gets simpler.
Key takeaways
The same sunscreen is an over-the-counter (OTC) drug in the US (FDA monograph order M020) and a cosmetic in the EU and UK. Pick the market before the SPF.
A US label needs a Drug Facts panel and monograph claims. An EU or UK label needs a safety file, a responsible person, and a CPNP notification.
Tattoo sunscreen is a leave-on format, so the EU microplastics deadline that touches it is 2029. Rinse-off formats go first, in 2027.
From September 2026, vague green claims need written proof under the EU consumer directive.
MOQ and lead time do not change with the rulebook. Match the tier to your launch stage.
By Hilook · Last reviewed: 2026-10-22. General information only, not legal advice.
The Trap: One Bottle, Two Rulebooks
A buyer can spec the same sunscreen formula and hear two completely different compliance stories depending on the destination market. Neither story is wrong. The product simply sits in two legal categories at once, and you choose which one applies by choosing where you sell.
Why the US Files Sunscreen as a Drug
The United States treats sunscreen as an over-the-counter drug under the FDA OTC monograph system. The rule lives in the FDA's OTC sunscreen monograph — first written as 21 CFR Part 352, now administered as final order M020 after the 2020 CARES Act reform. It sets the allowed active ingredients, the maximum SPF values, and the exact wording a label may use. A private label brand in the US does not invent its own sunscreen claims. It operates inside a fixed monograph, and any step outside that monograph needs a separate drug approval pathway.
Why Europe and the UK File It as a Cosmetic
The EU and the UK treat sunscreen as a cosmetic product under EC 1223/2009 and the UK Cosmetics Regulation, the UK's retained version of the EU regime. Here the active filters are cosmetic ingredients, not drug actives, and the brand carries responsibility for safety assessment rather than following a preset drug monograph. Claims follow cosmetic law, which gives more freedom on wording but demands a documented safety file and a named responsible party.
What the Split Does to Your Label
A US drug sunscreen must carry a Drug Facts panel, specific SPF and water resistance language, and monograph-approved claims. A European cosmetic sunscreen uses a cosmetic label with a different warning set, a different claims vocabulary, and a responsibility statement tied to its responsible person. Print a US-style drug claim on a bottle headed for Germany, or a cosmetic claim on a bottle headed for California, and the product can be flagged at the border or pulled from sale. The label is where the two rulebooks collide.
Aspect US (FDA Monograph) EU and UK (Cosmetic) Legal status Over-the-counter drug Cosmetic product Who sets claims Fixed monograph (M020 order) The brand, with proof Required label panel Drug Facts panel Cosmetic label and responsibility statement Key documents Establishment registration, product listing, GMP Responsible person, CPNP, PIF with safety report Claim freedom Closed set, no freelancing Broader, but every claim needs proof
Decide the Market Before the SPF
Most buyers list SPF numbers and bottle sizes first. That order puts the cart before the horse. The market decides which rulebook governs every later choice, so lock it down before you talk specs with a factory.
Hilook runs a that already supports brands across both regimes, and the first question in any brief is always the same: where will this sell?
Selling in the US Only
You live inside the FDA monograph. Your active ingredients, your SPF ceiling, and your permitted claims are preset. Pick a monograph-compliant formula, build the required Drug Facts panel, and complete establishment registration and product listing. You can move fast here because the rules are fixed, but you cannot freelance on claims.
Selling in the EU or UK Only
You follow cosmetic law. You need a responsible person established in the region, a Product Information File with a cosmetic safety report, and a CPNP notification before the product is placed on the market. Claims can be broader than in the US, but every claim needs written proof. This path rewards brands that can document their story.
Selling in Both Markets
Run two tracks from one formula. Keep a monograph-compliant US version with a Drug Facts panel, and a separate EU or UK cosmetic version with its safety file and responsible person. Many brands try to ship one label everywhere and learn the hard way that one label fits neither rulebook cleanly. Budget for two label sets and two document packages from the start.
Tip: Write the target market on line one of your brief. A factory can quote a useful number only after you name it.
SPF and Claims Under Each Rulebook
SPF is where buyers feel the most confident and get burned the most. The number looks universal, but what you may claim next to it changes completely by market.
US Drug Claims Under the FDA Monograph
Under the US monograph, SPF is a regulated drug claim. The label must state SPF as a fixed value, show broad spectrum status if claimed, and state water resistance as either 40 or 80 minutes. The word waterproof is not permitted, because no sunscreen is waterproof under FDA rules. A private label brand may not promise all-day protection or invent SPF language. The monograph is the ceiling, and the claim set is closed.
EU Claims After September 2026
In the EU, sunscreen claims sit under cosmetic law, which is more flexible on wording but stricter on proof. From late September 2026, the Empowering Consumers Directive (EU 2024/825) bars vague environmental or performance claims that lack evidence, so any green or protective claim now needs a paper trail. The broader Green Claims Directive proposal was withdrawn in 2025, but the consumer directive already tightens what you may say. We cover the environmental side in our piece on the , where the Entry 78 timeline is mapped in full.
SPF 30+ or 50+ Means Different Things
An SPF 30 or SPF 50 printed on a bottle means different things in each rulebook. In the US it is a monograph-defined drug claim with fixed testing and labeling. In the EU it is a cosmetic claim backed by your own proof file. The numeric value travels, but the proof behind it does not. When a factory offers private label tattoo sunscreen at SPF 30+ or SPF 50+, ask which rulebook the test report supports. A report built for one market may not satisfy the other.
Formula Choices That Shift by Market
Formula choices look technical, yet they are really decisions about where the product is legal. The same filter can be fine in one market and constrained in another.
Hilook's own is built for this dual standard, which is why we press clients on market before formula. See the full for the formats behind it. A filter that clears US monograph rules may still face a different test in Europe, and vice versa.
Entry 78 and the EU Timeline That Reaches Your Formula
The EU microplastics restriction under Entry 78 of Annex XVII to REACH targets intentionally added microplastics. Sunscreen is a leave-on format, so the deadline that touches it is 17 October 2029. Rinse-off formats go first, in 2027, which matters if your line also covers cleansers. A sunscreen formula that relies on certain polymer-based UV filters or film formers can fall inside this restriction in the EU while staying silent under US rules. Audit the formula for Entry 78 exposure now, because reformulation lead time is long.
Filters and Reef-Safe Claims
Reef-safe claims show the rule split clearly. The US federal monograph does not validate reef-safe language, so a US drug label cannot lean on it as a drug claim, while some US states restrict certain filters regardless. In the EU the claim is a cosmetic claim that needs proof under the 2026 consumer directive. A reef-safe tag is therefore a documentation question before it is a marketing one. Pick filters you can defend with a test file in every market you enter.
Documents Your OEM Must Provide
Name the document package in the brief, so you are not chasing papers after production.
For the US, your OEM should support:
FDA establishment registration and product listing under the OTC drug rules
Current good manufacturing practice (GMP) evidence
A monograph-aligned formulation record
You carry the registration as the brand owner, but a factory that cannot produce GMP documentation will stall your launch. Ask for these papers before you pay for a run, not after the bottles are filled.
For the EU or UK, you need:
A responsible person established in the region
A CPNP notification filed before market placement
A Product Information File with a cosmetic safety report
Without a responsible person the product cannot lawfully enter the market, so confirm who fills that role in your brief. This is the cosmetic rulebook's version of the Drug Facts panel, and it is not optional.
MOQ and Lead Time Stay the Same
After the rulebook questions, the commercial terms look identical no matter where you sell. That is why MOQ sits near the end of this article rather than the top. It is the least differentiating part of the brief, and suppliers compete on it openly.
For wholesale tattoo sunscreen buyers, the tiers below are the whole story. Supplier listings we reviewed showed private label sunscreen MOQs from as low as single digits on some listings up to 500 or 1,000+ on others, with standard formula lead times commonly quoted around 7 to 14 days and longer for custom development. A low MOQ suits a market test: you validate the label and the rulebook before committing volume. A higher MOQ suits a proven SKU where unit cost matters more than flexibility. The right tier depends on your launch stage, not on the regulation, because the same compliance work applies at any volume.
Tier Typical MOQ Best for What to expect Trial Low single digits to low hundreds Market test, new brand Higher unit cost, faster first run Standard Hundreds to low thousands Steady SKU Balanced cost and flexibility Bulk 1,000+ Proven volume Lowest unit cost, longer commitment
Build Your Brief Around the Rulebook
A brief built around the rulebook gives your OEM everything at once. Write it as a market-first document, not a spec-first document.
Target market: US only, EU or UK only, or both. State it on line one.
Rulebook: FDA monograph path, or cosmetic responsible person plus CPNP path, or both with two label sets.
SPF and claims: the exact SPF value and the claim set each market allows, with the test report that supports it.
Formula constraints: flag Entry 78 exposure and any reef-safe claim you intend to make, with proof.
Documents: name the registration, listing, GMP, responsible person, and CPNP items you expect back.
Commercials: wholesale tattoo sunscreen MOQ tier and lead time, kept separate because they apply regardless of market.
Confirm the market before the formula, collect the SPF and compliance documents up front, and pick an MOQ tier that matches your launch stage. When those are clear, the conversation with a factory gets short and productive. If you want a partner that already runs both rulebooks, with a team that builds private label tattoo sunscreen for the US and EU at once.
FAQ
Is sunscreen an OTC drug or a cosmetic?
In the United States, sunscreen is an over-the-counter drug under the FDA monograph, which fixes allowed actives and claims. In the EU and UK, it is a cosmetic with a safety file and a responsible person. The same bottle needs two different compliance paths, and your target market decides which one applies.
What SPF fits private label tattoo sunscreen?
Most formulas center on SPF 30+ or SPF 50+. In the US, SPF is a monograph drug claim with fixed testing; in the EU, it is a cosmetic claim backed by your own proof. Ask which rulebook the test report supports before you lock the number.
What MOQ fits private label tattoo sunscreen?
Listings range from single digits to 1,000+ units, with standard lead times of 7 to 14 days. Low MOQ suits a market test, where you validate the label and the rulebook first. Higher MOQ suits a proven SKU where unit cost matters. Pick the tier by launch stage, not by regulation.
Do US brands need FDA registration for sunscreen?
Yes. US sunscreen is an OTC drug, so the brand handles FDA establishment registration and product listing. Your factory should supply GMP documentation and a monograph-aligned formulation record. Ask for these before production, not after the bottles are filled.
What EU certificates do I need to sell sunscreen?
You need a responsible person in the region and a CPNP notification filed before market placement, backed by a Product Information File with a cosmetic safety report. Without a responsible person, the product cannot lawfully enter the market. Confirm who fills that role in your brief.
How long to develop a custom sunscreen formula?
Standard formulas run about 7 to 14 days. Custom formulas take longer, because changes to actives, texture, or claims need stability work and market-specific testing. Confirm the timeline against your target rulebook, since US and EU testing differ.
Can I private label regular sunscreen as tattoo sunscreen?
Yes. There is no separate legal category for tattoo sunscreen. What makes it tattoo sunscreen is the positioning: SPF protection for healed ink, ink-safe claims with written proof, and the same rulebook compliance as any sunscreen. The difference from regular sunscreen is marketing and claim proof, not a separate approval.
